<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-28T01:12:31+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>围城——工作篇</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/058t-cHI3-w29dUU7IP2UQ</id>
    <link href="https://mp.weixin.qq.com/s/058t-cHI3-w29dUU7IP2UQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布发布《中药复方制剂生产工艺研究技术指导原则（试行）》</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/PF0TK8PGPoq3fywZJpobJA</id>
    <link href="https://mp.weixin.qq.com/s/PF0TK8PGPoq3fywZJpobJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注册申报CPP文件，CDE最新规定来了！</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/3FbFYBBWduolPsYR3PDegg</id>
    <link href="https://mp.weixin.qq.com/s/3FbFYBBWduolPsYR3PDegg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国在研肿瘤药创新性分析</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/CgcznI53wxsx-U4YTgvLtA</id>
    <link href="https://mp.weixin.qq.com/s/CgcznI53wxsx-U4YTgvLtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告︱吴一龙：临床医生眼中的抗肿瘤新药临床研发</title>
    <updated>2020-11-27T20:09:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/zsYzA7rVktmbI9BLj8lF8A</id>
    <link href="https://mp.weixin.qq.com/s/zsYzA7rVktmbI9BLj8lF8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>市场监管总局等部门关于印发《粤港澳大湾区药品医疗器械监管创新发展工作方案》</title>
    <updated>2020-11-26T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/rVmuxCDnpdYsCaA7Qwci2w</id>
    <link href="https://mp.weixin.qq.com/s/rVmuxCDnpdYsCaA7Qwci2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传毒性杂质专栏——遗传毒性杂质风险评估简析（上）</title>
    <updated>2020-11-26T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/DPXuQi2HFZS6q67KxFztMQ</id>
    <link href="https://mp.weixin.qq.com/s/DPXuQi2HFZS6q67KxFztMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>图说 | 项目进度早知道！</title>
    <updated>2020-11-26T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/hk_Vv_O2IAOKsM9KEOYJag</id>
    <link href="https://mp.weixin.qq.com/s/hk_Vv_O2IAOKsM9KEOYJag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚｜CDE发布《药品审评中心补充资料工作程序（试行）》的通告</title>
    <updated>2020-11-25T22:30:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/ysjEG_IzTDDzVIEE8vkhqQ</id>
    <link href="https://mp.weixin.qq.com/s/ysjEG_IzTDDzVIEE8vkhqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE解答：药品申报中常见一般性技术问题解答</title>
    <updated>2020-11-25T22:30:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/x4u_UWKI9kNi1Hf3874Cfg</id>
    <link href="https://mp.weixin.qq.com/s/x4u_UWKI9kNi1Hf3874Cfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PPT译文 | 生物药剂学分类系统BCS 3类药物的生物豁免</title>
    <updated>2020-11-25T22:30:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/aep5ujOdCO9noib3YzRwpQ</id>
    <link href="https://mp.weixin.qq.com/s/aep5ujOdCO9noib3YzRwpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！CDE公开征求《疫苗临床试验抗体分析方法研究技术指导原则》意见</title>
    <updated>2020-11-24T21:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/_YPMNGzjMMYzv-wFttY1gg</id>
    <link href="https://mp.weixin.qq.com/s/_YPMNGzjMMYzv-wFttY1gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人乳头瘤病毒疫苗的申报现状及药学研发思考</title>
    <updated>2020-11-24T21:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/Zmqy4b6Pi7e_rYZNuGFVnw</id>
    <link href="https://mp.weixin.qq.com/s/Zmqy4b6Pi7e_rYZNuGFVnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《化学药品创新药I期临床试验申请药学共性问题相关技术要求》和《化学药品I期临床试验申请药学研究信息汇总表（修订版）》</title>
    <updated>2020-11-23T20:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/9MhE9daJWw66aN-h84fpGQ</id>
    <link href="https://mp.weixin.qq.com/s/9MhE9daJWw66aN-h84fpGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物宣布苏立信®（阿达木单抗注射液）在中国新适应症获批，治疗多关节型幼年特发性关节炎</title>
    <updated>2020-11-23T20:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/53zZK2CJUE6ucaHUOw3ytQ</id>
    <link href="https://mp.weixin.qq.com/s/53zZK2CJUE6ucaHUOw3ytQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2019年全国细菌耐药监测报告</title>
    <updated>2020-11-23T20:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/du1PSrMFQjK4RmsO-h8hkw</id>
    <link href="https://mp.weixin.qq.com/s/du1PSrMFQjK4RmsO-h8hkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（46）-粒细胞缺乏症</title>
    <updated>2020-11-22T18:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/jgTHgQhde_qtI-sv8hWLbw</id>
    <link href="https://mp.weixin.qq.com/s/jgTHgQhde_qtI-sv8hWLbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤微环境与免疫治疗耐药的关系及应对</title>
    <updated>2020-11-22T18:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/WQWE9WVslKJLrPNi45ta2g</id>
    <link href="https://mp.weixin.qq.com/s/WQWE9WVslKJLrPNi45ta2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物合成反应的后处理经验分享</title>
    <updated>2020-11-22T18:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/wDxozdr4_QVLc6lqO_lVzQ</id>
    <link href="https://mp.weixin.qq.com/s/wDxozdr4_QVLc6lqO_lVzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药企业加速布局CDK4/6靶点抑制剂</title>
    <updated>2020-11-21T20:06:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/JQV65srslY-kZ5itFp6Y_A</id>
    <link href="https://mp.weixin.qq.com/s/JQV65srslY-kZ5itFp6Y_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>